NIH Funding Cut Left Less Money On R&D Table, Tariffs Would Add To Woes: Aragen’s CEO

IPR Challenges In India Being Addressed

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.